583,800 Shares in Omada Health, Inc. $OMDA Purchased by Madryn Asset Management LP

Madryn Asset Management LP bought a new stake in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 583,800 shares of the company's stock, valued at approximately $12,814,410. Omada Health comprises about 0.0% of Madryn Asset Management LP's holdings, making the stock its 2nd biggest holding. Madryn Asset Management LP owned approximately 0.95% of Omada Health as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Quarry LP bought a new position in Omada Health in the fourth quarter valued at approximately $29,000. Raymond James Financial Inc. bought a new position in shares of Omada Health in the 2nd quarter valued at about $32,000. Versant Capital Management Inc increased its stake in shares of Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock worth $66,000 after purchasing an additional 2,283 shares during the last quarter. Strs Ohio raised its holdings in shares of Omada Health by 151.0% in the 4th quarter. Strs Ohio now owns 4,267 shares of the company's stock valued at $67,000 after purchasing an additional 2,567 shares during the period. Finally, New York State Common Retirement Fund acquired a new stake in Omada Health in the 4th quarter valued at about $73,000.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Wells Fargo & Company upped their price objective on shares of Omada Health from $17.00 to $18.00 and gave the company an "equal weight" rating in a report on Friday, May 8th. Citigroup restated an "outperform" rating on shares of Omada Health in a research note on Friday, August 14th. Evercore reaffirmed an "outperform" rating and set a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Robert W. Baird upped their price target on shares of Omada Health from $15.00 to $25.00 and gave the company a "neutral" rating in a research note on Wednesday, August 12th. Finally, Morgan Stanley reissued an "overweight" rating and issued a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $26.50.

Omada Health Price Performance

OMDA stock opened at $23.69 on Friday. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 473.80 and a beta of 1.73. The business's fifty day moving average price is $22.27 and its two-hundred day moving average price is $17.16.

Omada Health (NASDAQ:OMDA - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The company had revenue of $87.83 million during the quarter, compared to analysts' expectations of $80.93 million. Research analysts expect that Omada Health, Inc. will post 0.09 EPS for the current year.

Insider Buying and Selling

In related news, CAO Craig Gracey sold 1,042 shares of the business's stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $25.00, for a total value of $26,050.00. Following the completion of the transaction, the chief accounting officer owned 15,441 shares of the company's stock, valued at $386,025. The trade was a 6.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Steven L. Cook sold 1,607 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $25.01, for a total transaction of $40,191.07. Following the sale, the chief financial officer directly owned 187,209 shares of the company's stock, valued at $4,682,097.09. This represents a 0.85% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 254,726 shares of company stock valued at $5,370,496. 6.38% of the stock is currently owned by corporate insiders.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source